Skip to content

Drug interactions

Cyclophosphamide + Tucatinib

Severity: Moderate

Cyclophosphamide and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A4 and may alter cyclophosphamide metabolism. The net effect on active metabolite exposure is uncertain because cyclophosphamide is activated mainly by CYP2B6, but toxicity could change.

What this interaction means in plain words

Cyclophosphamide and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cyclophosphamide belongs to Oncology; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 inhibition by tucatinib may alter cyclophosphamide metabolism.

What to do

Monitor blood counts and for signs of cyclophosphamide toxicity. Reduce the cyclophosphamide dose if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cyclophosphamide and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cyclophosphamide with Tucatinib?

MediHelp rates the interaction as moderate. Cyclophosphamide and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits CYP3A4 and may alter cyclophosphamide metabolism. The net effect on active metabolite exposure is uncertain because cyclophosphamide is activated mainly by CYP2B6, but toxicity could change.

How serious is the interaction between Cyclophosphamide and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for signs of cyclophosphamide toxicity. Reduce the cyclophosphamide dose if toxicity develops.

What other medicines interact with Cyclophosphamide?

MediHelp also lists interactions of Cyclophosphamide with, for example, Adenovirus types 4 and 7 live, Belatacept, Bendamustine. The full list is on the Cyclophosphamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in